Literature DB >> 11544355

Biological weapons--a primer for microbiologists.

R J Hawley1, E M Eitzen.   

Abstract

Biological weapons are not new. Biological agents have been used as instruments of warfare and terror for thousands of years to produce fear and harm in humans, animals, and plants. Because they are invisible, silent, odorless, and tasteless, biological agents may be used as an ultimate weapon-easy to disperse and inexpensive to produce. Individuals in a laboratory or research environment can be protected against potentially hazardous biological agents by using engineering controls, good laboratory and microbiological techniques, personal protective equipment, decontamination procedures, and common sense. In the field or during a response to an incident, only personal protective measures, equipment, and decontamination procedures may be available. In either scenario, an immediate evaluation of the situation is foremost, applying risk management procedures to control the risks affecting health, safety, and the environment. The microbiologist and biological safety professional can provide a practical assessment of the biological weapons incident to responsible officials in order to help address microbiological and safety issues, minimize fear and concerns of those responding to the incident, and help manage individuals potentially exposed to a threat agent.

Entities:  

Mesh:

Year:  2001        PMID: 11544355     DOI: 10.1146/annurev.micro.55.1.235

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  37 in total

Review 1.  Current and developing technologies for monitoring agents of bioterrorism and biowarfare.

Authors:  Daniel V Lim; Joyce M Simpson; Elizabeth A Kearns; Marianne F Kramer
Journal:  Clin Microbiol Rev       Date:  2005-10       Impact factor: 26.132

2.  Effect of culture conditions on microorganism identification by matrix-assisted laser desorption ionization mass spectrometry.

Authors:  Nancy Valentine; Sharon Wunschel; David Wunschel; Catherine Petersen; Karen Wahl
Journal:  Appl Environ Microbiol       Date:  2005-01       Impact factor: 4.792

3.  Dynamics of the WPD loop of the Yersinia protein tyrosine phosphatase.

Authors:  Xin Hu; C Erec Stebbins
Journal:  Biophys J       Date:  2006-05-12       Impact factor: 4.033

4.  Reverse transcription-PCR-enzyme-linked immunosorbent assay for rapid detection and differentiation of alphavirus infections.

Authors:  Eryu Wang; Slobodan Paessler; Patricia V Aguilar; Anne-Sophie Carrara; Haolin Ni; Ivorlyne P Greene; Scott C Weaver
Journal:  J Clin Microbiol       Date:  2006-09-06       Impact factor: 5.948

5.  Treatment of Venezuelan equine encephalitis virus infection with (-)-carbodine.

Authors:  Justin G Julander; Richard A Bowen; Jagadeeshwar R Rao; Craig Day; Kristiina Shafer; Donald F Smee; John D Morrey; Chung K Chu
Journal:  Antiviral Res       Date:  2008-08-15       Impact factor: 5.970

6.  Historical Data Analysis of Hospital Discharges Related to the Amerithrax Attack in Florida.

Authors:  Lauralyn K Burke; C Perry Brown; Tammie M Johnson
Journal:  Perspect Health Inf Manag       Date:  2016-10-01

7.  Locking and blocking the viral landscape of an alphavirus with neutralizing antibodies.

Authors:  Jason Porta; Joyce Jose; John T Roehrig; Carol D Blair; Richard J Kuhn; Michael G Rossmann
Journal:  J Virol       Date:  2014-06-11       Impact factor: 5.103

8.  Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.

Authors:  Ann R Hunt; Richard A Bowen; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

9.  Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.

Authors:  Patricia V Aguilar; Slobodan Paessler; Anne-Sophie Carrara; Samuel Baron; Joyce Poast; Eryu Wang; Abelardo C Moncayo; Michael Anishchenko; Douglas Watts; Robert B Tesh; Scott C Weaver
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

10.  Improved efficacy of a gene optimised adenovirus-based vaccine for venezuelan equine encephalitis virus.

Authors:  Amanda J Williams; Lyn M O'Brien; Robert J Phillpotts; Stuart D Perkins
Journal:  Virol J       Date:  2009-07-31       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.